Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-015306
Filing Date
2020-06-04
Accepted
2020-06-04 19:21:00
Documents
2
Period of Report
2020-06-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4051
2 EX-24 DOCUMENT attachment1.htm EX-24 4390
  Complete submission text file 0000899243-20-015306.txt   9895
Mailing Address PORTOLA PHARMACEUTICALS, INC. 270 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
HOMCY CHARLES J (Reporting) CIK: 0001192591 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38959 | Film No.: 20944106

Mailing Address 421 KIPLING STREET PALO ALTO CA 94301
Business Address 421 KIPLING STREET PALO ALTO CA 94301 (650) 391-9740
BridgeBio Pharma, Inc. (Issuer) CIK: 0001743881 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations